Mark Zitter, MBA, Discusses Oncology Pathways

While findings around hospital and emergency department use were similar at the individual and neighborhood levels, the use of outpatient services differed.

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

A recent review highlights the gaps in clinical guidelines and treatment approaches for metabolic dysfunction-associated steatohepatitis (MASH) and looks ahead to the future promise of glucagon-like peptide 1 (GLP-1) receptor agonists for liver conditions.

On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.

Coverage from the Atlanta Regional meeting of the Institute for Value-Based Medicine.

Findings from the interviews offer insight into potential strategies for reducing binge eating among patients who experience food insecurity.